US Patent Issued to Texas Tech University System on Sept. 1 for "Alpha-methyl-L-tryptophan as an orally active drug for treating or preventing metabolic conditions" (Texas Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,836, issued on Sept. 1, was assigned to Texas Tech University System (Lubbock, Texas).

"Alpha-methyl-L-tryptophan as an orally active drug for treating or preventing metabolic conditions" was invented by Vadivel Ganapathy (Lubbock, Texas), Sathish Sivaprakasam (Lubbock, Texas), Yangzom D. Bhutia (Lubbock, Texas) and Sabarish Ramachandran (Lubbock, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the present disclosure pertain to methods of treating or preventing a condition in a subject by administering to the subject a composition having alpha-methyl-L-tryptophan. In additional embodiments, the method further includes a step of i...